EQ compared with PMN: revenue, margins and what each company keeps, and the suppliers and customers both name

EQEquillium, Inc.

Mkt capRevenueRevenue

PMNProMIS Neurosciences Inc.

Mkt capRevenueRevenue

Compare

EQEquillium, Inc.

PMNProMIS Neurosciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

EQEquillium, Inc.

1.38▼−2.90%· post 1.38

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

PMNProMIS Neurosciences Inc.

3.46▼−68.74%· post 3.77

ClosedOct 30 '26

Mkt cap$29.7MRevenue—Revenue—

Compare

ClosedOct 30 '26

EQEquillium, Inc.

PMNProMIS Neurosciences Inc.

1.38▼−2.90%post 1.38

Price

3.46▼−68.74%post 3.77

$86.9M

Mkt cap

$29.7M

Q4 FY24$4M

Revenue

—

FY24$41M

Revenue

—

EQ1.38▼−2.90%vsPMN3.46▼−68.74%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

EQ, solidPMN, dashed

Supply-chain overlap

Revenue flow

EQ: latest quarter is a loss; flow not drawable. PMN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only EQ 2

—Bioconunlistedsupplier

—Ono Pharmaceuticalunlistedcustomer

Shared 0

No disclosed counterparties: PMN.

Only PMN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR